Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions | Patent Number 11135312

US 11135312 B2
Application Number14487425
Publication NumberUS 20150104476 A1
Pendency7 years, 21 days
Filled DateSep 16, 2014
Priority DateJun 5, 2002
Publication DateApr 16, 2015
Expiration DateJun 5, 2022
Inventor/ApplicantsSteve Pascolo
Florian Von Der Mulbe
Ingmar Hoerr
ExaminesWOITACH, JOSEPH T
Art Unit1631
Technology Center1600
Assignments
Curevac Se
Current
Curevac Se
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.